BusinessPeregrine Pharmaceuticals to Present at Biotech Showcase 2018By Nasdaq OMXJan 2, 2018, 1:05 PM UTC
BusinessPeregrine Pharmaceuticals Announces Appointment of Roger J. Lias, Ph.D., as President and Chief Executive OfficerBy Nasdaq OMXDec 26, 2017, 1:05 PM UTC
BusinessPeregrine Pharmaceuticals to Report Financial Results for Second Quarter of Fiscal Year 2018 After Market Close on December 11, 2017By Nasdaq OMXDec 4, 2017, 9:05 PM UTC
BusinessIndoor Harvest and Harvest Air to Develop Integrated HVAC SolutionsBy Nasdaq OMXOct 26, 2017, 5:22 PM UTC
BusinessPeregrine Pharmaceuticals Announces Appointment of Patrick Walsh to Board of Directors of Peregrine and Avid BioservicesBy Nasdaq OMXOct 24, 2017, 12:05 PM UTC
BusinessPeregrine Pharmaceuticals Announces Appointment of Mark R. Bamforth to Board of Directors of Peregrine and Avid BioservicesBy Nasdaq OMXOct 19, 2017, 12:05 PM UTC
BusinessPeregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred StockBy Nasdaq OMXSep 5, 2017, 8:05 PM UTC
BusinessPeregrine to Report Financial Results for Third Quarter of Fiscal Year 2017 After Market Close on March 13, 2017By Nasdaq OMXMar 6, 2017, 1:05 PM UTC
